Division of Radiology 2, Department of Surgical and Biomedical Sciences, Santa Maria della Misericordia Hospital, Perugia, Italy.
Section of Anatomic Pathology and Histology, Department of Experimental Medicine, Santa Maria della Misericordia Hospital, Perugia, Italy.
Abdom Radiol (NY). 2019 Nov;44(11):3664-3673. doi: 10.1007/s00261-019-02012-4.
To determine the added value of qualitative and quantitative evaluation of diffusion-weighted magnetic resonance imaging (DWI) in locally advanced rectal cancer (LARC) restaging after neoadjuvant chemo-radiotherapy (CRT).
A retrospective study was performed of 21 patients with LARC treated with CRT. All patients were evaluated with 1.5 T conventional magnetic resonance imaging (MRI) and DWI (0-1000 s/mm²) before starting therapy and after neoadjuvant CRT. All included patients underwent surgery after CRT: the histopathological evaluation of surgical specimens represented the reference standard for local staging after neoadjuvant therapy. The qualitative analysis was carried out by two operators in consensus, who reviewed the conventional MR image set [T1-weighted and T2-weighted morphological sequences + dynamic contrast-enhanced sequences (DCE)] and the combined set of conventional and DW images. For the quantitative analysis, the apparent diffusion coefficient (ADC) values were measured at each examination. For each lesion, the mean ADC value (ADCpre and ADCpost) and the ΔADC (ADCpost - ADCpre) were calculated, and values of the three groups of response [complete response (pCR), partial response (pPR), stable disease (pSD)] were compared.
In LARC restaging, conventional MRI showed a sensitivity of 80% and a specificity of 50%, with a total diagnostic capacity of 71.40%, while by adding DWI sensitivity increased to 100%, specificity to 67%, and total diagnostic capacity to 90.40%. ΔADC correlates with treatment response and a cutoff of 1.35 × 10 mm²/s predicts the pCR with a sensitivity of 93.3% and a specificity of 83.3%.
Adding DWI to conventional sequences may improve MRI capability to evaluate tumor response to CRT. The quantitative DWI assessment is promising, but larger studies are required.
确定在新辅助放化疗(CRT)后局部晚期直肠癌(LARC)再分期中,扩散加权磁共振成像(DWI)的定性和定量评估的附加价值。
对 21 例接受 CRT 治疗的 LARC 患者进行回顾性研究。所有患者在开始治疗前和新辅助 CRT 后均进行 1.5 T 常规磁共振成像(MRI)和 DWI(0-1000 s/mm²)检查。所有纳入的患者在 CRT 后均接受手术:手术标本的组织病理学评估代表新辅助治疗后局部分期的参考标准。定性分析由两位操作员共同进行,他们共同审查常规 MRI 图像集[T1 加权和 T2 加权形态学序列+动态对比增强序列(DCE)]和常规和 DW 图像的组合图像。对于定量分析,在每次检查时测量表观扩散系数(ADC)值。对于每个病变,计算平均 ADC 值(ADCpre 和 ADCpost)和 ΔADC(ADCpost-ADCpre),并比较三组反应[完全缓解(pCR)、部分缓解(pPR)、稳定疾病(pSD)]的 ADC 值。
在 LARC 再分期中,常规 MRI 的敏感性为 80%,特异性为 50%,总诊断能力为 71.40%,而通过添加 DWI,敏感性增加到 100%,特异性增加到 67%,总诊断能力增加到 90.40%。ΔADC 与治疗反应相关,1.35×10 mm²/s 的截断值预测 pCR 的敏感性为 93.3%,特异性为 83.3%。
将 DWI 添加到常规序列中可能会提高 MRI 评估 CRT 后肿瘤反应的能力。定量 DWI 评估很有前景,但需要进行更大规模的研究。